| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |